ICAM1 and scleroderma: The presence of immunoglobulins (IgM or IgG) able to bind to immobilised recombinant human ICAM-1 was analysed in serum from 60 patients with scleroderma (n = 32 lSSc, n = 28 dSSc) and from 26 healthy controls.